Evidence map›Paper›PMID 31351238›Full record

ArticleNanomedicine : nanotechnology, biology, and medicine2019

Silver nanoparticles alter epithelial basement membrane integrity, cell adhesion molecule expression, and TGF-β1 secretion.

Megan E Martin, Denise K Reaves, Breanna Jeffcoat, Jeffrey R Enders, Lindsey M Costantini, Susan T Yeyeodu, Diane Botta, Terrance J Kavanagh, Jodie M Fleming

Open access · greenAbstract read
In one paragraph

Article in Nanomedicine : nanotechnology, biology, and medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Megan E MartinDepartment of Biological and Biomedical Sciences, North Carolina Central University, Durham, NC, USA.
Denise K ReavesDepartment of Biological and Biomedical Sciences, North Carolina Central University, Durham, NC, USA.
Breanna JeffcoatDepartment of Biological and Biomedical Sciences, North Carolina Central University, Durham, NC, USA.
Jeffrey R EndersMolecular Education, Technology and Research Innovation Center, North Carolina State University, Raleigh, NC, USA; Center for Human Health and the Environment, North Carolina State University, Raleigh, NC, USA.
Lindsey M CostantiniDepartment of Biological and Biomedical Sciences, North Carolina Central University, Durham, NC, USA.
Susan T YeyeoduCharles River Discovery Services, Morrisville, NC, USA.
Diane BottaDepartment of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.
Terrance J KavanaghDepartment of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.
Jodie M FlemingDepartment of Biological and Biomedical Sciences, North Carolina Central University, Durham, NC, USA; Center for Human Health and the Environment, North Carolina State University, Raleigh, NC, USA; Lineberger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: Jodie.fleming@nccu.edu.
North Carolina Central University · USUniversity of Washington · USNorth Carolina State University · USUniversity of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI Sheela Sathyanarayana · 1995 to 2026
$42.5M
Understanding Perceptions of HIV Risk, PrEP, and PrEP use among African American Women Attending an HBCUU54MD012392 · NIMHD · NORTH CAROLINA CENTRAL UNIVERSITY · PI Cherise Baldwin Harrington · 2017 to 2026
$38.1M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel · 2001 to 2026
$36.3M
Translational Research Support CoreP30ES025128 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Sue Fenton · 2015 to 2026
$18.3M
Targeting the MEKK2-ERK5 Signaling Node in Triple Negative Breast CancerU54CA156735 · NCI · NORTH CAROLINA CENTRAL UNIVERSITY · PI RICHARDSON, MICHELER RICARDO · 2010 to 2021
$13.0M
Project 3: Integrative Risk Assessment Methods for Engineered NanomaterialsU19ES019545 · NIEHS · UNIVERSITY OF WASHINGTON · PI KAVANAGH, TERRANCE J · 2010 to 2014
$5.6M
NCI NIH HHS P30 CA016086NCI NIH HHS U54 CA156735NIEHS NIH HHS P30 ES007033NIEHS NIH HHS P30 ES010126NIEHS NIH HHS P30 ES025128NIEHS NIH HHS U19 ES019545NIMHD NIH HHS U54 MD012392
6 · The paper itself

Abstract

Silver nanoparticles (AgNPs) are widely used in consumer and pharmaceutical products due to their antipathogenic properties. However, safety concerns have been raised due to their bioactive properties. While reports have demonstrated AgNPs can embed within the extracellular matrix, their effects on basement membrane (BM) production, integrin engagement, and tissue-integrity are not well-defined. This study analyzed the effects of AgNPs on BM production, composition and integrin/focal adhesion interactions in representative lung, esophageal, breast and colorectal epithelia models. A multidisciplinary approach including focused proteomics, QPCR arrays, pathway analyses, and immune-based, structural and functional assays was used to identify molecular and physiological changes in cell adhesions and the BM induced by acute and chronic AgNP exposure. Dysregulated targets included CD44 and transforming growth factor-beta, two proteins frequently altered during pathogenesis. Results indicate AgNP exposure interferes with BM and cell adhesion dynamics, and provide insight into the mechanisms of AgNP-induced disruption of epithelial physiology.

Indexed as

SilverBasement MembraneCell Adhesion MoleculesCell Line, TumorGene Expression RegulationHumansMetal NanoparticlesTransforming Growth Factor beta1Cell Adhesion MoleculesSilverTGFB1 protein, humanTransforming Growth Factor beta1Basement membraneCD44Epithelial cellsExtracellular matrixSilver nanoparticlesTransforming growth factor-beta

Identifiers

PMID31351238
PMCPMC6814557
OpenAlexW2963744228

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.